| Pharmaceutical active ingredients: |
| Cabergoline |
| Available forms, composition and doses of Cabaser: |
| Tablets; Oral; Cabergoline 1 mgTablets; Oral; Cabergoline 2 mgTablets; Oral; Cabergoline 4 mg |
| Cabaser medical category: |
| Human:Antiparkinsonian drugsDrugs affecting hormonal regulation |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G02CB03 - Cabergoline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerPerrigo |
| Related documents and information about Cabaser: |
| Cabaser prescribing information (PDF) |